CLINICAL ASPECT OF 02/03 IN RHEUMATIC DISEASES

. Z. Fahmy. Augusta-Klinik, 55543 Bad Kreuznach, Germany.

Among the disorders collectively named as rheumatism, progressive chronic polyarthritis constitutes a great problem, not only as regards to the frequency of its occurrence (1-2 % of the population), but also as regards its most effective therapy. Apart from non-medication (or physical) therapy methods, long-term antirheumatics, or so called basis therapeutics, represent the only medicaments known to have effects on the pathological processes involved, going beyond a symptomatic influence, contrary to the non-steroid antirheumatics and the corticoids.

In medical ozone research over the recent year, we have arrived at results with confirm the necessity for therapeutical application of an ozone-oxygene gas mixture, not only clinically, but also biochemically

Previous
Previous

IMMUNOLOGICAL FINDINGS IN THE PERIPHERAL BLOOD AND IN THE SYNOVIAL FLUID AFTER INTRAARTICULAR OZONE INJECTIONS IN RHEUMATOID ARTHRITIS

Next
Next

OUR EXPERIENCES IN THE USE OF OZONE THERAPY IN THE ELDERLY.